Custom-Made 3D-Printed Prosthesis after Resection of a Voluminous Giant Cell Tumour Recurrence in Pelvis.
custom-made cutting guides
custom-made prosthesis
giant-cell tumour
pelvis
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
29 Jan 2023
29 Jan 2023
Historique:
received:
26
12
2022
revised:
27
01
2023
accepted:
27
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
Giant-cell tumours are benign aggressive bone lesions that can affect any part of the skeleton. In early stages, curettage is preferred, but in case of local recurrence or voluminous lesions in the periacetabular region, wide resection and reconstruction are recommended. The purpose of this article is to increase clinicians' awareness of the importance of the follow-up of these patients and to describe a case of a voluminous recurrence of a giant-cell tumour in the pelvis. We present a 25-year-old female who underwent internal hemipelvectomy assisted by 3D cutting-guides and reconstruction with a custom-made 3D-printed pelvic prosthesis, hip arthroplasty and ilio-sacral arthrodesis. No postoperative complications occurred and, at long-term follow-up, the patient had a stable and painless hip joint, good bone-implant osteointegration, with an excellent functional outcome. In spite of all available reconstructive techniques, in well-selected patients with voluminous pelvic resections, custom-made 3D-printed implants allow patients to have a good mechanical outcome.
Identifiants
pubmed: 36766590
pii: diagnostics13030485
doi: 10.3390/diagnostics13030485
pmc: PMC9914636
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
J Bone Joint Surg Am. 1978 Sep;60(6):731-46
pubmed: 701308
Clin Orthop Relat Res. 1980 Nov-Dec;(153):106-20
pubmed: 7449206
Curr Oncol. 2022 Sep 05;29(9):6383-6399
pubmed: 36135072
Bone Joint J. 2021 Apr;103-B(4):795-803
pubmed: 33789467
J Arthroplasty. 2019 Feb;34(2):338-345.e1
pubmed: 30497901
Int Orthop. 2017 Nov;41(11):2397-2400
pubmed: 28646421
Clin Orthop Relat Res. 2013 Jan;471(1):324-31
pubmed: 23054524
Cancer Treat Res Commun. 2022;33:100634
pubmed: 36126512
Lancet Oncol. 2013 Aug;14(9):901-8
pubmed: 23867211
J Surg Oncol. 2011 Mar 1;103(3):269-75
pubmed: 21337556
Eur J Surg Oncol. 2014 Jan;40(1):27-33
pubmed: 24239184
Int Orthop. 2023 Jan;47(1):265-273
pubmed: 36282294
Clin Orthop Relat Res. 1993 Jan;(286):241-6
pubmed: 8425352
Musculoskelet Surg. 2022 Mar;106(1):21-27
pubmed: 32390095
BMC Surg. 2021 May 26;21(1):262
pubmed: 34039325
Arch Orthop Trauma Surg. 2015 May;135(5):619-25
pubmed: 25795428
J Bone Joint Surg Br. 2002 Apr;84(3):395-400
pubmed: 12002500
Clin Orthop Relat Res. 2020 May;478(5):1076-1085
pubmed: 31794487
Chin Med J (Engl). 2017 Nov 5;130(21):2541-2546
pubmed: 29067952
J Bone Joint Surg Am. 2018 Mar 21;100(6):496-504
pubmed: 29557866
Orthopedics. 2015 Feb;38(2):87-93
pubmed: 25665107
Cancer. 1998 Mar 1;82(5):851-9
pubmed: 9486573
J Clin Med. 2021 Aug 12;10(16):
pubmed: 34441834
Orthopedics. 2021 Nov-Dec;44(6):326-332
pubmed: 34618637
Orthop Traumatol Surg Res. 2019 Jun;105(4):781-787
pubmed: 30982774
J Surg Oncol. 2018 Nov;118(6):898-905
pubmed: 30261096
Surg Oncol. 2022 Jun;42:101733
pubmed: 35397377
World J Surg Oncol. 2016 Apr 05;14:104
pubmed: 27044392
Arch Orthop Trauma Surg. 2003 Sep;123(7):340-4
pubmed: 12838435
Cancer Treat Rev. 2010 Feb;36(1):1-7
pubmed: 19879054